Although we did not measure the G-CSF, GM-CSF, or IL-6 in the tumor cells, we compared the HE sections and several immunochemical markers in primary and recurrent tumors to investigate the possible factors related to the unusual presentation in our case. The gene discussed is CSF2; the disease is neoplasm.